The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Clevidipine Market Research Report 2025
Synopsis
Clevidipine (INN, trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable.
The global Clevidipine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Clevidipine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Clevidipine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Clevidipine in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Clevidipine include Chiesi Farmaceutici. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Clevidipine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clevidipine.
Report Scope
The Clevidipine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clevidipine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clevidipine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chiesi Farmaceutici
Segment by Type
25mg/50 mL Injectible Emulsion
50mg/100 mL Injectible Emulsion
125mg/ mL Injectible Emulsion
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clevidipine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Clevidipine (INN, trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable.
The global Clevidipine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Clevidipine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Clevidipine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Clevidipine in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Clevidipine include Chiesi Farmaceutici. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Clevidipine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clevidipine.
Report Scope
The Clevidipine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clevidipine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clevidipine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chiesi Farmaceutici
Segment by Type
25mg/50 mL Injectible Emulsion
50mg/100 mL Injectible Emulsion
125mg/ mL Injectible Emulsion
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clevidipine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clevidipine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 25mg/50 mL Injectible Emulsion
1.2.3 50mg/100 mL Injectible Emulsion
1.2.4 125mg/ mL Injectible Emulsion
1.3 Market by Application
1.3.1 Global Clevidipine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clevidipine Market Perspective (2019-2030)
2.2 Clevidipine Growth Trends by Region
2.2.1 Global Clevidipine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Clevidipine Historic Market Size by Region (2019-2024)
2.2.3 Clevidipine Forecasted Market Size by Region (2025-2030)
2.3 Clevidipine Market Dynamics
2.3.1 Clevidipine Industry Trends
2.3.2 Clevidipine Market Drivers
2.3.3 Clevidipine Market Challenges
2.3.4 Clevidipine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clevidipine Players by Revenue
3.1.1 Global Top Clevidipine Players by Revenue (2019-2024)
3.1.2 Global Clevidipine Revenue Market Share by Players (2019-2024)
3.2 Global Clevidipine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clevidipine Revenue
3.4 Global Clevidipine Market Concentration Ratio
3.4.1 Global Clevidipine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clevidipine Revenue in 2023
3.5 Clevidipine Key Players Head office and Area Served
3.6 Key Players Clevidipine Product Solution and Service
3.7 Date of Enter into Clevidipine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clevidipine Breakdown Data by Type
4.1 Global Clevidipine Historic Market Size by Type (2019-2024)
4.2 Global Clevidipine Forecasted Market Size by Type (2025-2030)
5 Clevidipine Breakdown Data by Application
5.1 Global Clevidipine Historic Market Size by Application (2019-2024)
5.2 Global Clevidipine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Clevidipine Market Size (2019-2030)
6.2 North America Clevidipine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Clevidipine Market Size by Country (2019-2024)
6.4 North America Clevidipine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clevidipine Market Size (2019-2030)
7.2 Europe Clevidipine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Clevidipine Market Size by Country (2019-2024)
7.4 Europe Clevidipine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clevidipine Market Size (2019-2030)
8.2 Asia-Pacific Clevidipine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Clevidipine Market Size by Region (2019-2024)
8.4 Asia-Pacific Clevidipine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clevidipine Market Size (2019-2030)
9.2 Latin America Clevidipine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Clevidipine Market Size by Country (2019-2024)
9.4 Latin America Clevidipine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clevidipine Market Size (2019-2030)
10.2 Middle East & Africa Clevidipine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Clevidipine Market Size by Country (2019-2024)
10.4 Middle East & Africa Clevidipine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Chiesi Farmaceutici
11.1.1 Chiesi Farmaceutici Company Detail
11.1.2 Chiesi Farmaceutici Business Overview
11.1.3 Chiesi Farmaceutici Clevidipine Introduction
11.1.4 Chiesi Farmaceutici Revenue in Clevidipine Business (2019-2024)
11.1.5 Chiesi Farmaceutici Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Clevidipine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 25mg/50 mL Injectible Emulsion
Table 3. Key Players of 50mg/100 mL Injectible Emulsion
Table 4. Key Players of 125mg/ mL Injectible Emulsion
Table 5. Global Clevidipine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Clevidipine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Clevidipine Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Clevidipine Market Share by Region (2019-2024)
Table 9. Global Clevidipine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Clevidipine Market Share by Region (2025-2030)
Table 11. Clevidipine Market Trends
Table 12. Clevidipine Market Drivers
Table 13. Clevidipine Market Challenges
Table 14. Clevidipine Market Restraints
Table 15. Global Clevidipine Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Clevidipine Market Share by Players (2019-2024)
Table 17. Global Top Clevidipine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clevidipine as of 2023)
Table 18. Ranking of Global Top Clevidipine Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Clevidipine Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Clevidipine Product Solution and Service
Table 22. Date of Enter into Clevidipine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Clevidipine Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Clevidipine Revenue Market Share by Type (2019-2024)
Table 26. Global Clevidipine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Clevidipine Revenue Market Share by Type (2025-2030)
Table 28. Global Clevidipine Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Clevidipine Revenue Market Share by Application (2019-2024)
Table 30. Global Clevidipine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Clevidipine Revenue Market Share by Application (2025-2030)
Table 32. North America Clevidipine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Clevidipine Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Clevidipine Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Clevidipine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Clevidipine Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Clevidipine Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Clevidipine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Clevidipine Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Clevidipine Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Clevidipine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Clevidipine Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Clevidipine Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Clevidipine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Clevidipine Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Clevidipine Market Size by Country (2025-2030) & (US$ Million)
Table 47. Chiesi Farmaceutici Company Detail
Table 48. Chiesi Farmaceutici Business Overview
Table 49. Chiesi Farmaceutici Clevidipine Product
Table 50. Chiesi Farmaceutici Revenue in Clevidipine Business (2019-2024) & (US$ Million)
Table 51. Chiesi Farmaceutici Recent Development
Table 52. Research Programs/Design for This Report
Table 53. Key Data Information from Secondary Sources
Table 54. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clevidipine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Clevidipine Market Share by Type: 2023 VS 2030
Figure 3. 25mg/50 mL Injectible Emulsion Features
Figure 4. 50mg/100 mL Injectible Emulsion Features
Figure 5. 125mg/ mL Injectible Emulsion Features
Figure 6. Global Clevidipine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Clevidipine Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Drug store Case Studies
Figure 10. Clevidipine Report Years Considered
Figure 11. Global Clevidipine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Clevidipine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Clevidipine Market Share by Region: 2023 VS 2030
Figure 14. Global Clevidipine Market Share by Players in 2023
Figure 15. Global Top Clevidipine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clevidipine as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Clevidipine Revenue in 2023
Figure 17. North America Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Clevidipine Market Share by Country (2019-2030)
Figure 19. United States Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Clevidipine Market Share by Country (2019-2030)
Figure 23. Germany Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Clevidipine Market Share by Region (2019-2030)
Figure 31. China Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Clevidipine Market Share by Country (2019-2030)
Figure 39. Mexico Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Clevidipine Market Share by Country (2019-2030)
Figure 43. Turkey Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Clevidipine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Chiesi Farmaceutici Revenue Growth Rate in Clevidipine Business (2019-2024)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
